The Indian glaucoma and cataract surgery devices market was valued at $164 million in 2016, and is expected to reach $321 million by 2023, registering a CAGR of 10.1% from 2017 to 2023. Glaucoma is a disease that causes vision loss owing to optic nerve damage. Cataract is the formation of dense, cloudy area that could affect the vision. The devices and instruments such as phacoemulsification systems, intraocular lenses, implants and stents, and glaucoma drainage aid in glaucoma and cataract surgical procedure to treat both the conditions efficiently.
Increase in prevalence of cataract disease as well as technological advancements in ophthalmic devices drives the market growth. Furthermore, increase in incidence of glaucoma and growth in geriatric population are projected to supplement the market growth. However, low awareness among people related to eye disorders and budget constrains caused by the high cost of these surgical devices hamper the market growth. Moreover, surge in investment by manufacturers in the emerging economies and rise in initiatives to reduce the burden of glaucoma offer profitable opportunities for market expansion.
The Indian glaucoma and cataract surgery devices market is segmented into product, surgery type, and end user. Based on product, the market is bifurcated into glaucoma and cataract surgery devices. The glaucoma surgery devices market is further divided into glaucoma drainage device, glaucoma laser device, and implant & stent. The cataract surgery device is further classified into intraocular lens (IOL), ophthalmic viscoelastic device (OVD), and phacoemulsification equipment. Based on the surgery type, glaucoma surgery is bifurcated into conventional glaucoma surgery and minimally invasive glaucoma surgery; whereas, cataract surgery is further classified into phacoemulsification, extracapsular cataract extraction (ECCE) surgery, femtosecond laser surgery, and others. The end users are classified into hospital, ophthalmology clinic, and outpatient surgical center. Based on zones, the market is classified into north zone, east zone, west zone, south zone, central zone, and north-east zone.
KEY MARKET BENEFITS FOR STAKEHOLDERS
KEY MARKET SEGMENTS
By Product
By Surgery Type
By End Users
By Zone
KEY PLAYERS PROFILED
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Local vs Import Glaucoma and Cataract Devices Analysis
3.4. Porters Five Forces Analysis
3.5. Market Dynamics
3.5.1. Drivers
3.5.1.1. Technological advancements in cataract and glaucoma surgery devices
3.5.1.2. Rise in geriatric population
3.5.1.3. Increase in focus on training for eye physicians and improve customer awareness
3.5.2. Restrains
3.5.2.1. Low awareness among people related to eye disorders
3.5.2.2. High cost of cataract and glaucoma surgeries and risk of post-operative complications associated with the glaucoma surgeries
3.5.3. Opportunity
3.5.3.1. Increase in transition toward minimally invasive surgeries for glaucoma treatment
CHAPTER 4: INDIAN GLAUCOMA AND CATARACT SURGERY DEVICES MARKET BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast, by product
4.2. Glaucoma Surgery Devices
4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast, by type
4.2.4. Market size and forecast, by zone
4.2.5. Implant & stent
4.2.5.1. Market size and forecast, by zone
4.2.6. Glaucoma drainage
4.2.6.1. Market size and forecast, by zone
4.2.7. Glaucoma laser device
4.2.7.1. Market size and forecast, by zone
4.3. Cataract Surgery Devices
4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast, by type
4.3.4. Market size and forecast, by zone
4.3.5. Intraocular lens
4.3.5.1. Market size and forecast, by zone
4.3.6. Ophthalmic viscoelastic device
4.3.6.1. Market size and forecast, by zone
4.3.7. Phacoemulsification system
4.3.7.1. Market size and forecast, by zone
CHAPTER 5: INDIAN GLAUCOMA AND CATARACT SURGERY DEVICES MARKET BY SURGERY TYPE
5.1. Overview
5.2. Glaucoma Surgery Type
5.2.1. Market size and forecast, by surgery type
5.2.2. Conventional glaucoma surgery
5.2.2.1. Market size and forecast, by zone
5.2.3. Minimally invasive glaucoma surgery
5.2.3.1. Market size and forecast, by zone
5.3. Cataract Surgery Type
5.3.1. Market size and forecast, by surgery type
5.3.2. Phacoemulsification
5.3.2.1. Market size and forecast, by zone
5.3.3. Extracapsular cataract extraction (ECCE) surgery
5.3.3.1. Market size and forecast, by zone
5.3.4. Femtosecond laser surgery
5.3.4.1. Market size and forecast, by zone
5.3.5. Others
5.3.5.1. Market size and forecast, by zone
CHAPTER 6: INDIAN GLAUCOMA AND CATARACT SURGERY DEVICES MARKET BY END USERS
6.1. Overview
6.1.1. Market size and forecast, by end user
6.2. Hospital
6.2.1. Market size and forecast, by zone
6.3. Ophthalmology Clinic
6.3.1. Market size and forecast, by zone
6.4. Outpatient Surgery Centers
6.4.1. Market size and forecast, by zone
CHAPTER 7: INDIAN GLAUCOMA AND CATARACT SURGERY DEVICES MARKET BY ZONE
7.1. Overview
7.1.1. Market size and forecast, by zone
7.2. North Zone
7.2.1. Market size and forecast, by product
7.2.2. Market size and forecast, by surgery type
7.2.3. Market size and forecast, by end users
7.3. East Zone
7.3.1. Market size and forecast, by product
7.3.2. Market size and forecast, by surgery type
7.3.3. Market size and forecast, by end users
7.4. West Zone
7.4.1. Market size and forecast, by product
7.4.2. Market size and forecast, by surgery type
7.4.3. Market size and forecast, by end users
7.5. South Zone
7.5.1. Market size and forecast, by product
7.5.2. Market size and forecast, by surgery type
7.5.3. Market size and forecast, by end users
7.6. Central Zone
7.6.1. Market size and forecast, by product
7.6.2. Market size and forecast, by surgery type
7.6.3. Market size and forecast, by end users
7.7. North-East Zone
7.7.1. Market size and forecast, by product
7.7.2. Market size and forecast, by surgery type
7.7.3. Market size and forecast, by end users
CHAPTER 8: COMPANY PROFILES
8.1. Allergan Plc.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. Carl Zeiss Meditec AG
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.3. Ellex Medical Lasers Ltd.
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.4. Essilor International S.A.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments
8.5. HOYA Corporation
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.6. Johnson & Johnson
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic moves and developments
8.7. Lumenis Ltd.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.8. Metall Zug AG (HAAG-Streit Holding AG)
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments
8.9. New World Medical, Inc.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Product portfolio
8.10. Nidek Co., Ltd.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments
8.11. Novartis International AG (Alcon Inc.)
8.11.1. Company overview
8.11.2. Company snapshot
8.11.3. Operating business segments
8.11.4. Product portfolio
8.11.5. Business performance
8.11.6. Key strategic moves and developments
8.12. Topcon Corporation.
8.12.1. Company overview
8.12.2. Company snapshot
8.12.3. Operating business segments
8.12.4. Product portfolio
8.12.5. Business performance
8.12.6. Key strategic moves and developments
8.13. Valeant pharmaceuticals International, Inc. (Bausch & Lomb Incorporated)
8.13.1. Company overview
8.13.2. Company snapshot
8.13.3. Operating business segments
8.13.4. Product portfolio
8.13.5. Business performance
8.13.6. Key strategic moves and developments
8.14. Ziemer Ophthalmic Systems AG
8.14.1. Company overview
8.14.2. Company snapshot
8.14.3. Product portfolio
LIST OF TABLES
TABLE 01. INDIAN GLAUCOMA AND CATARACT SURGERY DEVICES MARKET, BY PRODUCT, 20162023 ($MILLION)
TABLE 02. INDIAN GLAUCOMA SURGERY DEVICES MARKET, BY TYPE, 20162023 ($MILLION)
TABLE 03. INDIAN GLAUCOMA SURGERY DEVICES MARKET, BY ZONE, 20162023 ($MILLION)
TABLE 04. INDIAN GLAUCOMA IMPLANT & STENT SURGERY DEVICES MARKET, BY ZONE, 20162023 ($MILLION)
TABLE 05. INDIAN GLAUCOMA DRAINAGE SURGERY DEVICES MARKET, BY ZONE, 20162023 ($MILLION)
TABLE 06. INDIAN GLAUCOMA LASER SURGERY DEVICES MARKET, BY ZONE, 20162023 ($MILLION)
TABLE 07. INDIAN CATARACT SURGERY DEVICES MARKET, BY TYPE, 20162023 ($MILLION)
TABLE 08. INDIAN CATARACT SURGERY DEVICES MARKET, BY ZONE, 20162023 ($MILLION)
TABLE 09. INDIAN CATARACT SURGERY DEVICES MARKET FOR INTRAOCULAR LENS, BY ZONE, 20162023 ($MILLION)
TABLE 10. INDIAN CATARACT SURGERY DEVICES MARKET FOR OPHTHALMIC VISCOELASTIC DEVICE, BY ZONE, 20162023 ($MILLION)
TABLE 11. INDIAN CATARACT SURGERY DEVICES MARKET FOR PHACOEMULSIFICATION SYSTEM, BY ZONE, 20162023 ($MILLION)
TABLE 12. INDIAN GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE, 20162023 ($MILLION)
TABLE 13. INDIAN CONVENTIONAL GLAUCOMA SURGERY DEVICES MARKET, BY ZONE, 20162023 ($MILLION)
TABLE 14. INDIAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET, BY ZONE, 20162023 ($MILLION)
TABLE 15. INDIAN CATARACT SURGERY DEVICES MARKET, BY SURGERY TYPE, 20162023 ($MILLION)
TABLE 16. INDIAN PHACOEMULSIFICATION CATARACT SURGERY DEVICES MARKET, BY ZONE, 20162023 ($MILLION)
TABLE 17. INDIAN EXTRACAPSULAR CATARACT EXTRACTION SURGERY DEVICES MARKET, BY ZONE, 20162023 ($MILLION)
TABLE 18. INDIAN FEMTOSECOND LASER CATARACT SURGERY DEVICES MARKET, BY ZONE, 20162023 ($MILLION)
TABLE 19. INDIAN OTHER TYPES OF CATARACT SURGERY DEVICES MARKET, BY ZONE, 20162023 ($MILLION)
TABLE 20. INDIAN GLAUCOMA AND CATARACT SURGERY DEVICES MARKET, BY END USERS, 20162023 ($MILLION)
TABLE 21. INDIAN GLAUCOMA AND CATARACT SURGERY DEVICES MARKET FOR HOSPITAL, BY ZONE, 20162023 ($MILLION)
TABLE 22. INDIAN GLAUCOMA AND CATARACT SURGERY DEVICES MARKET FOR OPHTHALMOLOGY CLINIC, BY ZONE, 20162023 ($MILLION)
TABLE 23. INDIAN GLAUCOMA AND CATARACT SURGERY DEVICES MARKET FOR OUTPATIENT SURGICAL CENTER, BY ZONE, 20162023 ($MILLION)
TABLE 24. INDIAN GLAUCOMA AND CATARACT SURGERY DEVICES MARKET, BY ZONE, 20162023 ($MILLION)
TABLE 25. INDIAN GLAUCOMA AND CATARACT SURGERY DEVICES MARKET IN NORTH ZONE, BY PRODUCT, 20162023 ($MILLION)
TABLE 26. INDIAN GLAUCOMA SURGERY DEVICES MARKET IN NORTH ZONE, BY TYPE, 20162023 ($MILLION)
TABLE 27. INDIAN CATARACT SURGERY DEVICES MARKET IN NORTH ZONE, BY TYPE, 20162023 ($MILLION)
TABLE 28. INDIAN GLAUCOMA SURGERY DEVICES MARKET IN NORTH ZONE, BY SURGERY TYPE, 20162023 ($MILLION)
TABLE 29. INDIAN CATARACT SURGERY DEVICES MARKET IN NORTH ZONE, BY SURGERY TYPE, 20162023 ($MILLION)
TABLE 30. INDIAN GLAUCOMA AND CATARACT SURGERY DEVICES MARKET IN NORTH ZONE, BY END USERS, 20162023 ($MILLION)
TABLE 31. INDIAN GLAUCOMA AND CATARACT SURGERY DEVICES MARKET IN EAST ZONE, BY PRODUCT, 20162023 ($MILLION)
TABLE 32. INDIAN GLAUCOMA SURGERY DEVICES MARKET IN EAST ZONE, BY TYPE, 20162023 ($MILLION)
TABLE 33. INDIAN CATARACT SURGERY DEVICES MARKET IN EAST ZONE, BY TYPE, 20162023 ($MILLION)
TABLE 34. INDIAN GLAUCOMA SURGERY DEVICES MARKET IN EAST ZONE, BY SURGERY TYPE, 20162023 ($MILLION)
TABLE 35. INDIAN CATARACT SURGERY DEVICES MARKET IN EAST ZONE, BY SURGERY TYPE, 20162023 ($MILLION)
TABLE 36. INDIAN GLAUCOMA AND CATARACT SURGERY DEVICES MARKET IN EAST ZONE, BY END USERS, 20162023 ($MILLION)
TABLE 37. INDIAN GLAUCOMA AND CATARACT SURGERY DEVICES MARKET IN WEST ZONE, BY PRODUCT, 20162023 ($MILLION)
TABLE 38. INDIAN GLAUCOMA SURGERY DEVICES MARKET IN WEST ZONE, BY TYPE, 20162023 ($MILLION)
TABLE 39. INDIAN CATARACT SURGERY DEVICES MARKET IN WEST ZONE, BY TYPE, 20162023 ($MILLION)
TABLE 40. INDIAN GLAUCOMA SURGERY DEVICES MARKET IN WEST ZONE, BY SURGERY TYPE, 20162023 ($MILLION)
TABLE 41. INDIAN CATARACT SURGERY DEVICES MARKET IN WEST ZONE, BY SURGERY TYPE, 20162023 ($MILLION)
TABLE 42. INDIAN GLAUCOMA AND CATARACT SURGERY DEVICES MARKET IN WEST ZONE, BY END USERS, 20162023 ($MILLION)
TABLE 43. INDIAN GLAUCOMA AND CATARACT SURGERY DEVICES MARKET IN SOUTH ZONE, BY PRODUCT, 20162023 ($MILLION)
TABLE 44. INDIAN GLAUCOMA SURGERY DEVICES MARKET IN SOUTH ZONE, BY TYPE, 20162023 ($MILLION)
TABLE 45. INDIAN CATARACT SURGERY DEVICES MARKET IN SOUTH ZONE, BY TYPE, 20162023 ($MILLION)
TABLE 46. INDIAN GLAUCOMA SURGERY DEVICES MARKET IN SOUTH ZONE, BY SURGERY TYPE, 20162023 ($MILLION)
TABLE 47. INDIAN CATARACT SURGERY DEVICES MARKET IN SOUTH ZONE, BY SURGERY TYPE, 20162023 ($MILLION)
TABLE 48. INDIAN GLAUCOMA AND CATARACT SURGERY DEVICES MARKET IN SOUTH ZONE, BY END USERS, 20162023 ($MILLION)
TABLE 49. INDIAN GLAUCOMA AND CATARACT SURGERY DEVICES MARKET IN CENTRAL ZONE, BY PRODUCT, 20162023 ($MILLION)
TABLE 50. INDIAN GLAUCOMA SURGERY DEVICES MARKET IN CENTRAL ZONE, BY TYPE, 20162023 ($MILLION)
TABLE 51. INDIAN CATARACT SURGERY DEVICES MARKET IN CENTRAL ZONE, BY TYPE, 20162023 ($MILLION)
TABLE 52. INDIAN GLAUCOMA SURGERY DEVICES MARKET IN CENTRAL ZONE, BY SURGERY TYPE, 20162023 ($MILLION)
TABLE 53. INDIAN CATARACT SURGERY DEVICES MARKET IN CENTRAL ZONE, BY SURGERY TYPE, 20162023 ($MILLION)
TABLE 54. INDIAN GLAUCOMA AND CATARACT SURGERY DEVICES MARKET IN CENTRAL ZONE, BY END USERS, 20162023 ($MILLION)
TABLE 55. INDIAN GLAUCOMA AND CATARACT SURGERY DEVICES MARKET IN NORTH-EAST ZONE, BY PRODUCT, 20162023 ($MILLION)
TABLE 56. INDIAN GLAUCOMA SURGERY DEVICES MARKET IN NORTH-EAST ZONE, BY TYPE, 20162023 ($MILLION)
TABLE 57. INDIAN CATARACT SURGERY DEVICES MARKET IN NORTH-EAST ZONE, BY TYPE, 20162023 ($MILLION)
TABLE 58. INDIAN GLAUCOMA SURGERY DEVICES MARKET IN NORTH-EAST ZONE, BY SURGERY TYPE, 20162023 ($MILLION)
TABLE 59. INDIAN CATARACT SURGERY DEVICES MARKET IN NORTH-EAST ZONE, BY SURGERY TYPE, 20162023 ($MILLION)
TABLE 60. INDIAN GLAUCOMA AND CATARACT SURGERY DEVICES MARKET IN NORTH-EAST ZONE, BY END USERS, 20162023 ($MILLION)
TABLE 61. ALLERGAN: COMPANY SNAPSHOT
TABLE 62. ALLERGAN: OPERATING SEGMENTS
TABLE 63. ALLERGAN: PRODUCT PORTFOLIO
TABLE 64. CARL ZEISS: COMPANY SNAPSHOT
TABLE 65. CARL ZEISS: OPERATING SEGMENTS
TABLE 66. CARL ZEISS: PRODUCT PORTFOLIO
TABLE 67. ELLEX: COMPANY SNAPSHOT
TABLE 68. ELLEX: OPERATING SEGMENTS
TABLE 69. ELLEX: PRODUCT PORTFOLIO
TABLE 70. ESSILOR: COMPANY SNAPSHOT
TABLE 71. ESSILOR: PRODUCT SEGMENTS
TABLE 72. ESSILOR: PRODUCT PORTFOLIO
TABLE 73. HOYA: COMPANY SNAPSHOT
TABLE 74. HOYA: PRODUCT SEGMENTS
TABLE 75. HOYA: PRODUCT PORTFOLIO
TABLE 76. J&J: COMPANY SNAPSHOT
TABLE 77. J&J: OPERATING SEGMENTS
TABLE 78. J&J: PRODUCT PORTFOLIO
TABLE 79. LUMENIS: COMPANY SNAPSHOT
TABLE 80. LUMENIS: OPERATING SEGMENTS
TABLE 81. LUMENIS: PRODUCT PORTFOLIO
TABLE 82. METALL ZUG: COMPANY SNAPSHOT
TABLE 83. METALL ZUG: OPERATING SEGMENTS
TABLE 84. METALL ZUG: PRODUCT PORTFOLIO
TABLE 85. NWM: COMPANY SNAPSHOT
TABLE 86. NWM: PRODUCT PORTFOLIO
TABLE 87. NIDEK: COMPANY SNAPSHOT
TABLE 88. NIDEK: OPERATING SEGMENTS
TABLE 89. NIDEK: PRODUCT PORTFOLIO
TABLE 90. NOVARTIS AG: COMPANY SNAPSHOT
TABLE 91. NOVARTIS: OPERATING SEGMENTS
TABLE 92. NOVARTIS AG: PRODUCT PORTFOLIO
TABLE 93. TOPCON: COMPANY SNAPSHOT
TABLE 94. TOPCON: PRODUCT SEGMENTS
TABLE 95. TOPCON: PRODUCT PORTFOLIO
TABLE 96. VALEANT: COMPANY SNAPSHOT
TABLE 97. VALEANT: OPERATING SEGMENTS
TABLE 98. VALEANT: PRODUCT PORTFOLIO
TABLE 99. ZEIMER: COMPANY SNAPSHOT
TABLE 100. ZEIMER: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. INDIAN GLAUCOMA AND CATARACT SURGERY DEVICES MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2016-2018*
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2016-2018* (%)
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2016-2018*
FIGURE 06. INDIAN GLAUCOMA AND CATARACT SURGERY DEVICES MARKET, LOCAL MARKET VS IMPORT MARKET, 20162023 ($MILLION)
FIGURE 07. MODERATE BARGAINING POWER OF BUYERS
FIGURE 08. HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 09. HIGH THREAT OF NEW ENTRANTS
FIGURE 10. MODERATE THREAT OF SUBSTITUTION
FIGURE 11. HIGH COMPETITIVE RIVALRY
FIGURE 12. ALLERGAN: NET SALES, 20152017 ($MILLION)
FIGURE 13. ALLERGAN: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 14. CARL ZEISS: NET SALES, 20152017 ($MILLION)
FIGURE 15. CARL ZEISS: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 16. CARL ZEISS: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 17. ELLEX: NET SALES, 20152017 ($MILLION)
FIGURE 18. ELLEX: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 19. ELLEX: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 20. ESSILOR: NET SALES, 20142016 ($MILLION)
FIGURE 21. ESSILOR: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 22. ESSILOR: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 23. HOYA: NET SALES, 20152017 ($MILLION)
FIGURE 24. HOYA: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 25. HOYA: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 26. J&J: NET SALES, 20152017 ($MILLION)
FIGURE 27. J&J: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 28. J&J: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 29. METALL ZUG: NET SALES, 20152017 ($MILLION)
FIGURE 30. METALL ZUG: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 31. METALL ZUG: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 32. NIDEK: NET SALES, 20142016 ($MILLION)
FIGURE 33. NIDEK: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 34. NIDEK: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 35. NOVARTIS: NET SALES, 20152017 ($MILLION)
FIGURE 36. NOVARTIS: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 37. NOVARTIS: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 38. TOPCON: NET SALES, 20152017 ($MILLION)
FIGURE 39. TOPCON: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 40. TOPCON: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 41. VALEANT: NET SALES, 20152017 ($MILLION)
FIGURE 42. VALEANT: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 43. VALEANT: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
Contact us at the Consulting WP office nearest to you or submit a business inquiry online.
Subscribe to Our Newsletter
Published On : December 2019
$ 3600
Published On : December 2019
$ 3600
